Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00116207
Status:
COMPLETED
Last Update Posted:
2016-07-29
First Post:
2005-06-27
Brief Title:
An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes
Sponsor:
University of Michigan
Organization:
University of Michigan
Study Overview
Official Title:
Oxidative Stress and Cardiovascular Denervation in Diabetes An Interventional Trial
Status:
COMPLETED
Status Verified Date:
2016-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The focus of this project is cardiovascular diabetic autonomic neuropathy DAN DAN affects the nerves that control heart rate and blood flow to the heart in people with diabetes DAN may cause problems with the rhythm of the heartbeat or decrease blood flow to the heart Three medications will be tested for their effectiveness in DAN
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None